Brochstein JA - Search Results

1

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.

Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM, Arai S, Grupp SA, Guinan EC, Martin PL, Steinbach G, Krishnan A, Nemecek ER, Giralt S, Rodriguez T, Duerst R, Doyle J, Antin JH, Smith A, Lehmann L, Champlin R, Gillio A, Bajwa R, D'Agostino RB Sr, Massaro J, Warren D, Miloslavsky M, Hume RL, Iacobelli M, Nejadnik B, Hannah AL, Soiffer RJ. Richardson PG, et al. Among authors: brochstein ja. Blood. 2016 Mar 31;127(13):1656-65. doi: 10.1182/blood-2015-10-676924. Epub 2016 Jan 29. Blood. 2016. PMID: 26825712 Free PMC article. Clinical Trial.

2

Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.

Corbacioglu S, Kernan N, Lehmann L, Brochstein J, Revta C, Grupp S, Martin P, Richardson PG. Corbacioglu S, et al. Expert Rev Hematol. 2012 Jun;5(3):291-302. doi: 10.1586/ehm.12.18. Expert Rev Hematol. 2012. PMID: 22780209 Review.

3

Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host disease.

Brochstein JA, Grupp S, Yang H, Pillemer SR, Geba GP. Brochstein JA, et al. Pediatr Transplant. 2010 Mar;14(2):233-41. doi: 10.1111/j.1399-3046.2009.01223.x. Epub 2009 Aug 11. Pediatr Transplant. 2010. PMID: 19671093 Clinical Trial.

4

Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation.

Gillio AP, Boulad F, Small TN, Kernan NA, Reyes B, Childs BH, Brochstein JA, Laver J, Castro-Malaspina H, O'Reilly RJ. Gillio AP, et al. Among authors: brochstein ja. Biol Blood Marrow Transplant. 1997 Apr;3(1):18-24. Biol Blood Marrow Transplant. 1997. PMID: 9209737

5

Graft-versus-host disease treatment: predictors of survival.

Levine JE, Logan B, Wu J, Alousi AM, Ho V, Bolaños-Meade J, Weisdorf D; Blood and Marrow Transplant Clinical Trials Network. Levine JE, et al. Biol Blood Marrow Transplant. 2010 Dec;16(12):1693-9. doi: 10.1016/j.bbmt.2010.05.019. Epub 2010 Jun 9. Biol Blood Marrow Transplant. 2010. PMID: 20541024 Free PMC article. Clinical Trial.

6

Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience.

Heath JA, Kurland G, Spray TL, Kernan NA, Small TN, Brochstein JA, Gillio AP, Boklan J, O'Reilly RJ, Boulad F. Heath JA, et al. Among authors: brochstein ja. Transplantation. 2001 Dec 27;72(12):1986-90. doi: 10.1097/00007890-200112270-00020. Transplantation. 2001. PMID: 11773900

7

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.

Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N. Shenoy S, et al. Among authors: brochstein j. Blood. 2016 Nov 24;128(21):2561-2567. doi: 10.1182/blood-2016-05-715870. Epub 2016 Sep 13. Blood. 2016. PMID: 27625358 Free PMC article. Clinical Trial.

8

Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.

Boulad F, Steinherz P, Reyes B, Heller G, Gillio AP, Small TN, Brochstein JA, Kernan NA, O'Reilly RJ. Boulad F, et al. Among authors: brochstein ja. J Clin Oncol. 1999 Jan;17(1):197-207. doi: 10.1200/JCO.1999.17.1.197. J Clin Oncol. 1999. PMID: 10458234

9

Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome.

Brochstein JA, Gillio AP, Ruggiero M, Kernan NA, Emanuel D, Laver J, Small T, O'Reilly RJ. Brochstein JA, et al. J Pediatr. 1991 Dec;119(6):907-12. doi: 10.1016/s0022-3476(05)83041-0. J Pediatr. 1991. PMID: 1960605

10

Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin.

Kernan NA, Byers V, Scannon PJ, Mischak RP, Brochstein J, Flomenberg N, Dupont B, O'Reilly RJ. Kernan NA, et al. JAMA. 1988 Jun 3;259(21):3154-7. JAMA. 1988. PMID: 3285046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page